[Prognostic implictions of the lack of a lipid-lowering strategy].
Baessler
A
A
Klinikum der Universität Regensburg, Klinik und Poliklinik für Innere Medizin II, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg.
Fischer
M
M
Hubauer
U
U
Stark
K
K
Hengstenberg
W
W
Wiedmann
S
S
Neureuther
K
K
Holmer
S
S
Mayer
B
B
Schunkert
H
H
Hengstenberg
C
C
D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000401:mortality; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D055502:Secondary Prevention; D015996:Survival Rate
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors